What is the prevalence of Psoriasis?

Psoriasis is a common, chronic immune-mediated condition affecting approximately 2% to 3% of the global population, though prevalence varies significantly by region and ethnicity.

While Psoriasis is classified as a common condition rather than a rare disease, it is frequently underdiagnosed or mismanaged, leading to variations in official epidemiological reporting. According to the National Psoriasis Foundation, more than 8 million Americans are currently living with Psoriasis. Incidence rates are difficult to pinpoint precisely, but data suggest that the condition can emerge at any age, typically presenting in two peaks: one between the ages of 15 and 30, and a second between 50 and 60.

Demographics and Variations

• Gender Distribution: Clinical studies generally indicate that Psoriasis affects males and females with roughly equal frequency.


• Geographic and Ethnic Trends: Prevalence is highest in populations of Northern European descent and lower in populations of African, Asian, or Indigenous American heritage, suggesting a complex interplay between genetic predisposition and environmental triggers.


• Underdiagnosis: Many individuals with mild forms of Psoriasis may never seek formal medical intervention, meaning true prevalence likely exceeds current clinical estimates.

Real-World Perspectives

In our DiseaseMaps.org community, we see firsthand how the lived experience of this condition transcends statistics. With 815 members sharing their journeys, we observe that the daily impact of Psoriasis—ranging from plaque management to systemic inflammation—often goes beyond what clinical prevalence data can capture. These patient-reported outcomes provide a vital, complementary layer of evidence to the broader medical literature, highlighting the diverse ways this condition manifests across different populations.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• National Psoriasis Foundation (NPF)


• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs